Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice

Pan,Wensen; Han,Shuo; Kang,Lin; Li,Sha; Du,Juan; Cui,Huixian

doi:10.3892/etm.2016.3470

Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice

Authors:
- Wensen Pan
- Shuo Han
- Lin Kang
- Sha Li
- Juan Du
- Huixian Cui
View Affiliations

Affiliations: Department of Human Anatomy, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China
Published online on: June 21, 2016 https://doi.org/10.3892/etm.2016.3470
Pages: 1455-1463
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The current study focused on how dihydrotestosterone (DHT) regulates synaptic plasticity in the hippocampus of mild cognitive impairment male senescence-accelerated mouse prone 8 (SAMP8) mice. Five‑month‑old SAMP8 mice were divided into the control, castrated and castrated-DHT groups, in which the mice were castrated and treated with physiological doses of DHT for a period of 2 months. To determine the regulatory mechanisms of DHT in the cognitive capacity, the effects of DHT on the morphology of the synapse and the expression of synaptic marker proteins in the hippocampus were investigated using immunohistochemistry, qPCR and western blot analysis. The results showed that the expression of cAMP‑response element binding protein (CREB), postsynaptic density protein 95 (PSD95), synaptophysin (SYN) and developmentally regulated brain protein (Drebrin) was reduced in the castrated group compared to the control group. However, DHT promoted the expression of CREB, PSD95, SYN and Drebrin in the hippocampus of the castrated‑DHT group. Thus, androgen depletion impaired the synaptic plasticity in the hippocampus of SAMP8 and accelerated the development of Alzheimer's disease (AD)‑like neuropathology, suggesting that a similar mechanism may underlie the increased risk for AD in men with low testosterone. In addition, DHT regulated synaptic plasticity in the hippocampus of mild cognitive impairment (MCI) SAMP8 mice and delayed the progression of disease to Alzheimer's dementia. In conclusion, androgen‑based hormone therapy is a potentially useful strategy for preventing the progression of MCI in aging men. Androgens enhance synaptic markers (SYN, PSD95, and Drebrin), activate CREB, modulate the fundamental biology of synaptic structure, and lead to the structural changes of plasticity in the hippocampus, all of which result in improved cognitive function.

View Figures

View References

1	Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, et al: The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7:270–279. 2011. View Article : Google Scholar : PubMed/NCBI
2	Alzheimer's Association: 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 9:208–245. 2013. View Article : Google Scholar : PubMed/NCBI
3	Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B and Phelps CH: Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7:257–262. 2011. View Article : Google Scholar : PubMed/NCBI
4	Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, et al: Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7:280–292. 2011. View Article : Google Scholar : PubMed/NCBI
5	DeCarli C: Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
6	Petersen RC: Mild cognitive impairment: Current research and clinical implications. Semin Neurol. 27:22–31. 2007. View Article : Google Scholar : PubMed/NCBI
7	Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG and Kokmen E: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1397–1403. 1999. View Article : Google Scholar : PubMed/NCBI
8	Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA and Kordower JH: Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 158:469–490. 1999. View Article : Google Scholar : PubMed/NCBI
9	Price JL and Morris JC: Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer's disease. Ann Neurol. 45:358–368. 1999. View Article : Google Scholar : PubMed/NCBI
10	Lautenschlager NT, Riemenschneider M, Drzezga A and Kurz AF: Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord. 12:379–386. 2001. View Article : Google Scholar : PubMed/NCBI
11	Hogervorst E, Bandelow S, Combrinck M and Smith AD: Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 39:1633–1639. 2004. View Article : Google Scholar : PubMed/NCBI
12	Hogervorst E, Combrinck M and Smith AD: Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 24:203–208. 2003.PubMed/NCBI
13	Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M and Smith AD: Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett. 22:163–168. 2001.PubMed/NCBI
14	Paoletti AM, Congia S, Lello S, Tedde D, Orrù M, Pistis M, Pilloni M, Zedda P, Loddo A and Melis GB: Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 62:301–303. 2004. View Article : Google Scholar : PubMed/NCBI
15	Watanabe T, Koba S, Kawamura M, Itokawa M, Idei T, Nakagawa Y, Iguchi T and Katagiri T: Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 53:476–482. 2004. View Article : Google Scholar : PubMed/NCBI
16	Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M and Mayeux R: Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology. 54:833–837. 2000. View Article : Google Scholar : PubMed/NCBI
17	Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM and Resnick SM: Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 87:5001–5007. 2002. View Article : Google Scholar : PubMed/NCBI
18	Tsolaki M, Grammaticos P, Karanasou C, Balaris V, Kapoukranidou D, Kalpidis I, Petsanis K and Dedousi E: Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia. Hell J Nucl Med. 8:39–42. 2005.PubMed/NCBI
19	Chu LW, Tam S, Wong RL, Yik PY, Song Y, Cheung BM, Morley JE and Lam KS: Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men. J Alzheimers Dis. 21:1335–1345. 2010.PubMed/NCBI
20	Pike CJ, Rosario ER and Nguyen TV: Androgens, aging, and Alzheimer's disease. Endocrine. 29:233–241. 2006. View Article : Google Scholar : PubMed/NCBI
21	Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, Wang L, Herman M, Figueroa H, Yu WH, et al: A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis. 31:46–57. 2008. View Article : Google Scholar : PubMed/NCBI
22	Corbyn Z: New set of Alzheimer's trials focus on prevention. Lancet. 381:614–615. 2013. View Article : Google Scholar : PubMed/NCBI
23	Ambati J and Fowler BJ: Mechanisms of age-related macular degeneration. Neuron. 75:26–39. 2012. View Article : Google Scholar : PubMed/NCBI
24	Bisaz R, Boadas-Vaello P, Genoux D and Sandi C: Age-related cognitive impairments in mice with a conditional ablation of the neural cell adhesion molecule. Learn Mem. 20:183–193. 2013. View Article : Google Scholar : PubMed/NCBI
25	Woolley CS and McEwen BS: WoolleyCS: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci. 12:2549–2554. 1992.PubMed/NCBI
26	Scheff SW and Price DA: Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J Neuropathol Exp Neurol. 57:1146–1153. 1998. View Article : Google Scholar : PubMed/NCBI
27	Leranth C, Petnehazy O and MacLusky NJ: Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 23:1588–1592. 2003.PubMed/NCBI
28	Takeda T, Hosokawa M and Higuchi K: Senescence-accelerated mouse (SAM): A novel murine model of senescence. Exp Gerontol. 32:105–109. 1997. View Article : Google Scholar : PubMed/NCBI
29	Tresguerres JA, Kireev R, Forman K, Cuesta S, Tresguerres AF and Vara E: Effect of chronic melatonin administration on several physiological parameters from old Wistar rats and SAMP8 mice. Curr Aging Sci. 5:242–253. 2012. View Article : Google Scholar : PubMed/NCBI
30	Morley JE, Farr SA, Kumar VB and Armbrecht HJ: The SAMP8 mouse: A model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des. 18:1123–1130. 2012. View Article : Google Scholar : PubMed/NCBI
31	Kang L, Li S, Xing Z, Li J, Su Y, Fan P, Wang L and Cui H: Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer's disease in SAMP8 mice. Horm Behav. 65:505–515. 2014. View Article : Google Scholar : PubMed/NCBI
32	Jia J, Kang L, Li S, Geng D, Fan P, Wang L and Cui H: Amelioratory effects of testosterone treatment on cognitive performance deficits induced by soluble Aβ1-42 oligomers injected into the hippocampus. Horm Behav. 64:477–486. 2013. View Article : Google Scholar : PubMed/NCBI
33	Li S, Kang L, Zhang C, Xie G, Li N, Zhang Y, Du J and Cui H: Effects of dihydrotestosterone on synaptic plasticity of hippocampus in male SAMP8 mice. Exp Gerontol. 48:778–785. 2013. View Article : Google Scholar : PubMed/NCBI
34	Ma J, Zhang Z, Su Y, Kang L, Geng D, Wang Y, Luan F, Wang M and Cui H: Magnetic stimulation modulates structural synaptic plasticity and regulates BDNF-TrkB signal pathway in cultured hippocampal neurons. Neurochem Int. 62:84–91. 2013. View Article : Google Scholar : PubMed/NCBI
35	Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE and Scheff SW: Mild cognitive impairment: Pathology and mechanisms. Acta Neuropathol. 123:13–30. 2012. View Article : Google Scholar : PubMed/NCBI
36	Terakawa Y, Agnihotri S, Golbourn B, Nadi M, Sabha N, Smith CA, Croul SE and Rutka JT: The role of drebrin in glioma migration and invasion. Exp Cell Res. 319:517–528. 2013. View Article : Google Scholar : PubMed/NCBI
37	Tu JC, Xiao B, Naisbitt S, et al: Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron. 23:583–592. 1999. View Article : Google Scholar : PubMed/NCBI
38	Du H, Guo L, Yan S, Sosunov AA, McKhann GM and Yan SS: Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci USA. 107:18670–18675. 2010. View Article : Google Scholar : PubMed/NCBI
39	Hatanaka Y, Mukai H, Mitsuhashi K, Hojo Y, Murakami G, Komatsuzaki Y, Sato R and Kawato S: Androgen rapidly increases dendritic thorns of CA3 neurons in male rat hippocampus. Biochem Biophys Res Commun. 381:728–732. 2009. View Article : Google Scholar : PubMed/NCBI
40	Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM and Resnick SM: Free testosterone and risk for Alzheimer disease in older men. Neurology. 62:188–193. 2004. View Article : Google Scholar : PubMed/NCBI
41	Selkoe DJ: Preventing Alzheimer's disease. Science. 337:1488–1492. 2012. View Article : Google Scholar : PubMed/NCBI
42	Bell KF and Claudio Cuello A: Altered synaptic function in Alzheimer's disease. Eur J Pharmacol. 545:11–21. 2006. View Article : Google Scholar : PubMed/NCBI
43	Bilkei-Gorzo A: Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacol Ther. 142:244–257. 2014. View Article : Google Scholar : PubMed/NCBI
44	Demartini DR, Schilling LP, da Costa JC and Carlini CR: Alzheimer's and Parkinson's diseases: An environmental proteomic point of view. J Proteomics. 104:24–36. 2014. View Article : Google Scholar : PubMed/NCBI
45	Balthazart J, Baillien M, Charlier TD and Ball GF: Calcium-dependent phosphorylation processes control brain aromatase in quail. Eur J Neurosci. 17:1591–1606. 2003. View Article : Google Scholar : PubMed/NCBI
46	Takeuchi Y, Miyamoto E and Fukunaga K: Activation of the rat dopamine D2 receptor promoter by mitogen-activated protein kinase and Ca2+/calmodulin-dependent protein kinase II pathways. J Neurochem. 83:784–796. 2002. View Article : Google Scholar : PubMed/NCBI
47	Ishida A, Shigeri Y, Taniguchi T and Kameshita I: Protein phosphatases that regulate multifunctional Ca2+/calmodulin-dependent protein kinases: From biochemistry to pharmacology. Pharmacol Ther. 100:291–305. 2003. View Article : Google Scholar : PubMed/NCBI
48	Ooishi Y, Kawato S, Hojo Y, Hatanaka Y, Higo S, Murakami G, Komatsuzaki Y, Ogiue-Ikeda M, Kimoto T and Mukai H: Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen and androgen. J Steroid Biochem Mol Biol. 131:37–51. 2012. View Article : Google Scholar : PubMed/NCBI
49	Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ and Hyman BT: Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci. 25:7278–7287. 2005. View Article : Google Scholar : PubMed/NCBI
50	Voineskos D, Rogasch NC, Rajji TK, Fitzgerald PB and Daskalakis ZJ: A review of evidence linking disrupted neural plasticity to schizophrenia. Can J Psychiatry. 58:86–92. 2013.PubMed/NCBI
51	Sheng M and Kim MJ: Postsynaptic signaling and plasticity mechanisms. 298:776–780. 2002.
52	Hernandez PJ and Abel T: The role of protein synthesis in memory consolidation: Progress amid decades of debate. Neurobiol Learn Mem. 89:293–311. 2008. View Article : Google Scholar : PubMed/NCBI
53	Hasan A, Nitsche MA, Rein B, Schneider-Axmann T, Guse B, Gruber O, Falkai P and Wobrock T: Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation. Behav Brain Res. 224:15–22. 2011. View Article : Google Scholar : PubMed/NCBI
54	Honer WG, Dickson DW, Gleeson J and Davies P: Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging. 13:375–382. 1992. View Article : Google Scholar : PubMed/NCBI
55	Davidsson P and Blennow K: Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int Psychogeriatr. 10:11–23. 1998. View Article : Google Scholar : PubMed/NCBI
56	Harigaya Y, Shoji M, Shirao T and Hirai S: Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res. 43:87–92. 1996. View Article : Google Scholar : PubMed/NCBI
57	Gardoni F, Marcello E and Di Luca M: Postsynaptic density-membrane associated guanylate kinase proteins (PSD- MAGUKs) and their role in CNS disorders. Neuroscience. 158:324–333. 2009. View Article : Google Scholar : PubMed/NCBI
58	Kirchberg BC, Cohen JR, Adelsky MB, Buthorn JJ, Gomar JJ, Gordon M, Koppel J, Christen E, Conejero-Goldberg C, Davies P, et al: Semantic distance abnormalities in mild cognitive impairment: Their nature and relationship to function. Am J Psychiatry. 169:1275–1283. 2012. View Article : Google Scholar : PubMed/NCBI
59	Verma M and Howard RJ: Semantic memory and language dysfunction in early Alzheimer's disease: A review. Int J Geriatr Psychiatry. 27:1209–1217. 2012. View Article : Google Scholar : PubMed/NCBI
60	Kwon SE and Chapman ER: Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron. 70:847–854. 2011. View Article : Google Scholar : PubMed/NCBI
61	Sultana R, Banks WA and Butterfield DA: Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res. 88:469–477. 2010.PubMed/NCBI
62	Leranth C, Hajszan T and MacLusky NJ: Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 24:495–499. 2004. View Article : Google Scholar : PubMed/NCBI
63	Counts SE, He B, Nadeem M, Wuu J, Scheff SW and Mufson EJ: Hippocampal drebrin loss in mild cognitive impairment. Neurodegener Dis. 10:216–219. 2012. View Article : Google Scholar : PubMed/NCBI
64	Pugazhenthi S, Wang M, Pham S, Sze CI and Eckman CB: Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons. Mol Neurodegener. 6:602011. View Article : Google Scholar : PubMed/NCBI
65	Satoh J, Tabunoki H and Arima K: Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis Markers. 27:239–252. 2009. View Article : Google Scholar : PubMed/NCBI
66	Saura CA and Valero J: The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci. 22:153–169. 2011. View Article : Google Scholar : PubMed/NCBI